Targeting of δ-catenin to postsynaptic sites through interaction with the Shank3 N-terminus.
Fatemeh Hassani Nia, Daniel Woike, Victoria Martens and 4 others
PMID 33115499WHAT IT FOUND
The Shank3 protein anchors δ-catenin to synapses via its N-terminus.
Removing this anchor reduces δ-catenin at postsynaptic sites in mouse brain and cultured neurons, without changing total δ-catenin levels. This identifies a specific molecular mechanism linking two autism-related proteins.
Key findings
01δ-catenin binds directly to the Ankyrin repeats of the Shank3 N-terminus.
02Loss of Shank3 isoforms containing the N-terminus significantly reduces δ-catenin levels in the postsynaptic density of mice.
03Expressing full-length Shank3 in neurons increases δ-catenin localization at postsynaptic sites, while a Shank3 construct lacking the N-terminus fails to do so.
STILL TO COME
How it was doneWhat they found
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study relies on mouse models and cultured rat neurons, which may not fully replicate human brain physiology. Commercial antibodies for endogenous δ-catenin were unsuitable for immunocytochemistry, forcing reliance on overexpressed fluorescent constructs. Rodent cDNA constructs were used, which may behave differently than human sequences despite high similarity. This is a mechanistic molecular biology study; it does not measure behavioral, speech, or motor outcomes in patients.
Declared interests
The authors declare no competing interests. Funding was provided by the Deutscher Akademischer Austauschdienst, Deutsche Forschungsgemeinschaft, and Projekt DEAL.
The easy way to misread this
Do not interpret this as evidence that targeting this molecular interaction will improve autism symptoms. The study describes a cellular mechanism in mice and cell cultures; it does not report clinical outcomes or test any intervention in humans.